Introduction
. All known AKAPs contain a putative amphipathic Voltage-gated calcium channels mediate the influx of helix, which is required for their ability to bind the RII calcium into excitable cells during depolarizing stimuli dimer (Carr et al., 1991) . A peptide spanning the RIIand thereby initiate calcium-dependent processes inbinding domain of the human thyroid AKAP, HT31 (Carr cluding neurotransmitter release, hormone secretion, et al., 1992) , disrupts PKA-mediated maintenance of and muscle contraction (Tsien, 1983; Bean, 1989; Hess, basal glutamate receptor activity in hippocampal neu-1990). In skeletal muscle transverse tubules, L-type rons (Rosenmund et al., 1994) and blocks voltage-depencalcium channels mediate increases in intracellular caldent potentiation of calcium channels (Johnson et al., cium through two distinct mechanisms (reviewed in Cat-1994 Cat- , 1997 ). These results indicate that an AKAP-mediterall, 1991). A fast mechanism involving direct coupling ated association of PKA and the skeletal muscle calcium of the L-type calcium channel to ryanodine-sensitive channel is required for voltage-dependent potentiation. calcium release channels in the sarcoplasmic reticulum Cardiac and brain L-type calcium channels are also regis thought to provide the calcium required for contraculated by voltage-dependent potentiation (Sculptoreanu tion (Tanabe et al., 1990; Ríos et al., 1991; Lu et al., et al., 1993b; Bourinet et al., 1994) , and regulation of the 1994), while a slower mechanism in which calcium encardiac calcium channel requires an AKAP (Gao et al., ters directly through the L-type calcium channel is 1997). Thus, this mechanism of calcium channel regulathought to play an important role in replenishing intration may have widespread significance in excitable cells. cellular calcium stores and controlling contractile force
To define the molecular mechanism underlying volt- (Oz and Frank, 1991) .
age-dependent potentiation of skeletal muscle calcium Skeletal muscle L-type calcium channels mediate channels, we have focused on identifying and characterslowly activated, long-lasting calcium currents (Sanchez izing the AKAP involved. AKAP15, a 15 kDa PKA-binding and Stefani, 1978; Schwartz et al., 1985) . Like cardiac protein, copurifies with the skeletal muscle calcium channel complex (Gray et al., 1997) . Here we describe the isolation, primary sequence determination, and func- ‡ To whom correspondence should be addressed.
tional characterization of AKAP15. Our results show that § Present address: Neurocrine Biosciences, Inc., 3050 Science Park
Road, San Diego, CA 92121-1102.
AKAP15 targets PKA to calcium channels by membrane (A) SDS-PAGE analysis of fractions collected during purification of AKAP15. Rabbit skeletal muscle microsomes (membranes), supernatant following pH 12 washing and repelleting of insoluble membranes (pH 12 wash), and resuspended pH 12-washed Triton X-100-solubilized membranes (Triton X-100 sol) were loaded in equal proportion. Triton X-100-solubilized material was loaded onto a DEAE column and the flow-through (FT), wash, and fractions collected over a gradient from 0 to 500 mM NaCl were collected. All samples were separated by SDS-PAGE, electrotransferred to nitrocellulose, and assayed for AKAP15 via the RII-biotin overlay.
(B) DEAE fractions containing AKAP15 were pooled and loaded onto an RII affinity column. Pooled DEAE fractions (DEAE), flow-through (FT), wash, and AKAP15 elute samples were loaded in equal proportion, separated by SDS-PAGE, electrotransferred to nitrocellulose, and assayed for AKAP15 via the RIIbiotin overlay assay. (D) Amino acid sequence alignment of the rat and human AKAP15 proteins. The region of the rat sequence corresponding to the AP2 peptide is indicated with a solid line, and the AP1 peptide sequence is indicated with a dashed line. The region predicted to be helical is shaded, with the amphipathic portion denoted by double bars. The N-terminal acylation domain required for membrane association is boxed with the putative acylated residues indicated by asterisks.
association through a lipid anchor and by direct interacRabbit skeletal muscle microsomal membranes were therefore used as the starting material for the isolation of tion with calcium channels. Inhibition of AKAP15 with a competing peptide blocks voltage-dependent potentia-AKAP15. The two higher molecular weight bands ( Figure  1A ) are not AKAPs and represent avidin binding proteins, tion, supporting an essential role for this novel AKAP in mediating the PKA anchoring required for potentiation since they were detected in the presence of avidin-HRP alone (data not shown). of skeletal muscle calcium channels and regulation of contractile force.
Initially, we tested the possibility that AKAP15 is peripherally associated with skeletal muscle membranes via protein-protein interactions by using chaoResults tropic agents, acidic washes, and alkaline washes. Despite these harsh conditions, which should disrupt most Isolation and Primary Sequence Determination of AKAP15 protein-protein interactions, AKAP15 remained membrane associated ( Figure 1A ; data not shown). These L-type calcium channels are highly enriched in skeletal muscle transverse tubule membranes (Fosset et al., 1983) , results suggested that AKAP15 is either an integral membrane protein or tightly anchored to the membrane from which they were originally purified (Curtis and Catterall, 1984) . We previously showed that AKAP15 is asvia covalent lipid modification. Washing skeletal muscle membranes with 10 mM CAPS (pH 12), while failing to sociated with purified rabbit skeletal muscle L-type calcium channels (Gray et al., 1997) , suggesting it might remove AKAP15 from the membrane ( Figure 1A ), removed the majority of the membrane-associated proalso be enriched in the skeletal muscle membrane fraction. To test this, we prepared rabbit skeletal muscle teins and was therefore included as a purification step.
Having determined that we could not recover AKAP15 membranes and probed for AKAPs via the RII-biotin overlay assay. Figure 1A shows that AKAP15 is present in an aqueous-soluble form, we proceeded by solubilization of alkaline-washed microsomal membranes in Triin the membrane fraction and that it is the major AKAP detected. AKAP15 was not detected in the cytosolic ton X-100 and sequential purification by DEAE anion exchange and RII affinity chromatography to enrich for fraction from rabbit skeletal muscle (data not shown). (A) GST, AKAP15 purified from rabbit skeletal muscle (AKAP15), and recombinant GST-AKAP15 samples were resolved by SDS-PAGE, electrotransferred to nitrocellulose, and visualized following treatment with either an anti-GST antibody or RII-biotin. (B) A helical wheel diagram is shown representing residues 28-41 of AKAP15 within the predicted helical domain. The hydrophobic face of the helix is shaded and the position of the L32P mutation is indicated. (C) The leucine residue at position 32 was mutated to proline via site-directed mutagenesis and the resulting mutant was expressed as a GST-fusion protein. Equivalent amounts of wild-type (GST-wt) and proline-substituted GST-AKAP15 (GST-L32P) were analyzed by Western blot probing with either anti-AP1 antibody or RII-biotin. (D) Equivalent amounts of GST-AKAP15 were resolved via SDS-PAGE, electrotransferred to nitrocellulose, and overlaid with RII-biotin preincubated without peptide (control) or with 100 nM AP2, 100 nM AP2-P, 500 nM HT31, or 500 nM HT31-P. Figures 1A and 1B) . Using this purification have predicted molecular weights of 9153 for the rat protein and 8968 for the human protein. These predicted scheme, we were able to obtain AKAP15-containing fractions eluted from the RII affinity column with a specific molecular weights are significantly less than the observed migration of AKAP15 in SDS-PAGE gels. This RII␣ binding activity that was increased approximately 4000-fold when compared to crude membranes.
AKAP15 (
anomalous migration is consistent with the possibility that AKAP15 is posttranslationally modified. When we For mass spectrometric analysis, approximately 10 pmol of affinity-purified AKAP15 was subjected to SDSused the entire rat and human cDNA sequences in BLASTN and BLASTX searches against GenBank, nei-PAGE and stained with Coomasie blue. The resultant AKAP15 band was excised and subjected to in-gel trypther matched any existing sequence with significant similarity, suggesting that these cDNAs represent a sin digestion (Shevchenko et al., 1996) . Soluble tryptic peptides recovered from the digestion were analyzed novel gene present in both humans and rats. via microcolumn HPLC and automated tandem mass spectrometry (Yates et al., 1995) . The acquired tandem Expression and RII-Binding Properties of AKAP15 AKAPs identified to date, while sharing the functional mass spectra were used to search the nucleotide databases translated in all six reading frames using the comproperty of binding RII with high affinity, do not share appreciable primary sequence similarity. This made it puter program SEQUEST (Eng et al., 1994) . This led to the identification of a tryptic peptide, which matched impossible for us to confirm whether we had identified an AKAP gene based simply on sequence comparisons. sequence from a rat expressed sequence tag (EST). This peptide, which we named AP1 (AVQQYLEETQNKK), Therefore, we expressed the protein specified by the originally identified rat open reading frame in bacteria is not present in GenBank, indicating that it derives from a previously uncharacterized protein. Searching the daas a fusion protein linked to glutathione-S-transferase (GST) and tested its ability to bind RII in the RII-biotin tabase of expressed sequence tags (dbEST) with the entire rat EST sequence, we further identified a homolooverlay assay. Figure 2 shows that the resulting GST fusion protein ( Figure 2A , left) is detected by the RII gous human EST containing a portion of the AP1 sequence.
overlay assay (Figure 2A , right), while GST alone is not. This functional assay demonstrates that the rat cDNA Both the rat and human EST clones were obtained from Genome Systems, Inc., and sequenced. Each cDNA was we identified encodes an AKAP. approximately 2.2 kb and possessed a short open reading frame specifying an 81-amino acid protein conIdentification of a Region in AKAP15 Required for RII Binding taining the AP1 peptide sequence ( Figures 1C and 1D ). The putative proteins encoded by these two open readAll characterized AKAPs have been shown to contain an amphipathic helix that is critical for high affinity RII ing frames are 78% identical at the amino acid level and In parallel experiments, nitrocellulose blots containing immunoprecipitated, labeled AKAP15 were cut into strips that were subjected directly to scintillation counting (right). (C) tsA-201 cells were transiently transfected with either wild-type or the indicated AKAP15 mutant, lysed, and subjected to a low speed spin to remove nuclei and mitochondria and then a high speed spin to separate membrane (M) and soluble (S) material. Proportional amounts of these fractions were resolved via SDS-PAGE, electrotransferred to nitrocellulose, and detected via the RII-biotin overlay.
binding (Dell'Acqua and Scott, 1997). Secondary strucMutation of a Consensus Sequence for Acylation Blocks Membrane Targeting of AKAP15 ture prediction programs indicate that the AKAP15 protein contains a helical domain of approximately 25 amino As mentioned previously, AKAP15 was not removed from skeletal muscle membranes using conditions that acid residues spanning the middle third of the protein ( Figure 1D ). Further analysis of this predicted helix redisrupt protein-protein interactions. In fact, we were only able to recover this protein in soluble form using vealed a strongly amphipathic region, which we have illustrated with a helical wheel ( Figure 2B ). With other detergents. This tight association of AKAP15 with the membrane suggested that it might contain one or more AKAPs, disruption of the secondary structure of their amphipathic helices by replacing native helical residues transmembrane segments or be covalently modified with a lipid anchor. While AKAP15 does not contain a likely with prolines blocks high affinity RII binding (Carr et al., 1991 (Carr et al., , 1992 ). Therefore, we tested whether the putatransmembrane domain, it does contain an N-terminal sequence similar to that of proteins known to be memtive amphipathic helix we identified in AKAP15 binds RII.
Initially, we generated a mutant GST-AKAP15 fusion brane targeted via myristoylation and/or palmitoylation (reviewed in Resh, 1994; Mumby, 1997 ). An amino acid protein in which a leucine residue at position 32 in the middle of the amphipathic region was replaced with a sequence alignment comparing residues 2-11 of AKAP15 and dually acylated G␣ proteins and src-related tyrosine proline residue ( Figure 2B ). Figure 2C shows that this mutant was unable to bind RII in the RII-biotin overlay kinases is illustrated in Figure 3A . Each of these proteins possesses an N-terminal myristoylated glycine residue assay compared to the wild-type fusion protein when equal amounts of both mutant and wild-type fusion proas well as one or more proximal palmitoylated cysteine residues. AKAP15 possesses an N-terminal glycine resitein were loaded. To further demonstrate the RII-binding properties of the amphipathic helix region, we synthedue as well as cysteine residues at positions 5 and 6, suggesting that it may be myristoylated and palmitoysized a 25 residue peptide, designated AP2, which spans the entire predicted helical region of AKAP15 (Figlated . Dual acylation of these residues may mediate the association of AKAP15 with skeletal muscle membranes ure 1D). To characterize the ability of the AP2 peptide to bind RII, we tested its ability to competitively inhibit by providing one or more covalently attached lipid anchors. RII-AKAP binding in the RII overlay assay. When preincubated with RII-biotin, this peptide prevented AKAP15
To test for posttranslational modification of AKAP15, we heterologously expressed AKAP15 in the tsA-201 detection at concentrations as low as 100 nM, while the same peptide containing two proline substitutions in the subclone of HEK 293 human embryonic kidney cells. Expressed in this system, AKAP15 migrates with the amphipathic region had minimal effect ( Figure 2D ). As expected, HT31 peptide also inhibited RII-AKAP15 bindsame apparent molecular mass of 15 kDa observed in skeletal muscle preparations ( Figures 3B and 3C ). Growth ing, but the proline-substituted control did not ( Figure  2D ). Thus, the predicted helical domain within AKAP15 of transfected cells in [ assessed by immunoprecipitation and SDS-PAGE analysis ( Figure 3B ). These results show that AKAP15 contains myristoyl and palmitoyl moieties, which likely account for its behavior as an intrinsic membrane protein.
To examine the role of these lipid moieties in subcellular distribution of AKAP15, we measured the distribution of wild-type and mutant AKAP15 between the membrane and cytosolic compartments. In order to assess whether myristoylation is required to ensure targeting of AKAP15 to the membrane, we mutated the N-terminal glycine residue of AKAP15 to alanine to prevent myristoylation. Figure 3C shows that this mutation caused only a small fraction of the AKAP15 protein to appear in the soluble fraction following expression in tsA-201 cells. This suggests that myristoylation increases targeting of AKAP15 to the membrane fraction but is not absolutely required for it. When we expressed a mutant 
AKAP15 Coimmunoprecipitates with the L-Type
patterns are merged ( Figure 5C ). These results confirm Calcium Channel Following Coexpression that AKAP15 and calcium channels are associated with in tsA-201 Cells the triad junctions in intact skeletal muscle fibers and We have shown previously that AKAP15 coimmunopresupport a role for AKAP15 in targeting PKA to the calcipitates with L-type calcium channels purified from cium channel. Thus, AKAP15 must contain amino acid skeletal muscle (Gray et al., 1997) . In order to test sequences that are important for its restricted localizawhether this interaction occurs in nonmuscle cells, tion in transverse tubules in addition to its membrane AKAP15 and the calcium channel were coexpressed in targeting domain. tsA-201 cells. Membranes were prepared from cotransfected cells and analyzed via Western blotting and RII-AKAP15 Is Required for Voltage-Dependent biotin overlay. Figure 4 shows that both the calcium Potentiation of L-Type Calcium Channels channel ␣ 1 subunit (the full-length protein migrating at in Skeletal Muscle Cells ‫012ف‬ kDa and a prominent proteolytic fragment migratVoltage-dependent potentiation of L-type calcium chaning at ‫87ف‬ kDa) and AKAP15 were expressed and presnels has previously been characterized in 129CB3 cells, ent in the membrane fraction. An antibody directed a skeletal muscle cell line. These studies demonstrated against the calcium channel ␣ 1 subunit coprecipitates that potentiation requires PKA that is anchored near the AKAP15 from the membrane fraction of these cells, channel by an AKAP (Johnson et al., 1994) . AKAP15 is demonstrating that the recombinant calcium channel physically associated with the skeletal muscle L-type and AKAP15 interact when heterologously expressed calcium channel complex (Gray et al., 1997) and colo- (Figure 4 ). This result indicates that AKAP15 and the calizes with calcium channels in skeletal muscle transcalcium channel do not require the context of a muscle verse tubules ( Figure 5 ). Together, these results suggest cell to interact and is consistent with direct binding of AKAP15 may mediate the PKA anchoring required for AKAP15 to the channel as suggested by the copurificachannel potentiation. To test this directly, we introduced tion and coimmunoprecipitation of these two proteins.
an AKAP15-derived peptide (AP2) containing the RIIbinding domain into intact 129CB3 skeletal muscle cells and measured its effect on voltage-dependent potentiaColocalization of L-Type Calcium Channels and AKAP15 in Skeletal Muscle tion. When the AP2 peptide is introduced into cells, the small calcium current recorded at Ϫ20 mV under control Immunohistochemical techniques were used to determine the subcellular localization of AKAP15 in adult rat conditions is not affected, but voltage-dependent potentiation of calcium channel activity is substantially reskeletal muscle tissue and to compare it to that of the L-type calcium channel. Figure 5 shows that both AKAP15 duced ( Figures 6A and 6B ). In contrast, the prolinesubstituted AP2-P peptide (AKAP15-P) does not bind and L-type calcium channels are concentrated in skeletal muscle transverse tubules, as revealed by the pattern RII and has no effect on potentiation ( Figures 6A and  6B ). These results show that the RII-binding domain of of paired punctate localizations of the two proteins. Double-labeling experiments show a clear colocalization of AKAP15 is capable of blocking potentiation in intact cells, likely by displacing PKA from the endogenous these proteins when images of their respective staining clamp mode from 129CB3 mouse skeletal muscle myotubes. (C) The images in (A) and (B), above, were merged to determine (A) Examples of calcium channel potentiation following a conditioncolocalization of AKAP15 and the calcium channel in rat skeletal ing prepulse in myotubes to which 100 M AP2 peptide (AKAP15) muscle. Yellow immunoflourescence indicates colocalization. Scale and 200 M AP2-P (AKAP15-P) peptides were applied through the bar ϭ 10 m. patch pipette. The voltage-clamp protocol used to measure channel potentiation was as follows. A 300 ms test pulse is applied to Ϫ20 mV to measure channel activation under control conditions. After a 3 s recovery interval, a 200 ms conditioning prepulse is applied to AKAP15 associated with the calcium channel complex.
ϩ80 mV that strongly activates the calcium channel. After a brief
These results together with the colocalization and co-(20 ms) recovery interval at Ϫ60 mV, a second test pulse is applied purification of AKAP15 with the calcium channel support for 300 ms to Ϫ20 mV to test channel activation. The ratio of the the conclusion that AKAP15 is responsible for calcium current measured at the end of the two test pulses (after and before the conditioning prepulse) is used as the measure of channel potenchannel potentiation by PKA phosphorylation in skeletal tiation. Test pulse currents were normalized to the same amplitudes muscle cells.
before the prepulse to allow direct comparison of potentiation following the prepulse. Data are representative of eight and six experi-
Tissue Distribution of AKAP15
ments with AP2 and AP2-P peptides, respectively.
To investigate the tissue distribution of AKAP15, a cDNA we have characterized in this study is approximately 2.2 kb, not including its poly A tail, and is likely derived from this 2.4 kb transcript. Figure 7 also shows visible in testis (Figure 7) . The presence of AKAP15 in heart and brain suggests that it may be involved in calthe presence of a larger transcript of approximately 3.6 kb, which is present in all tissues examined with the poscium channel modulation in those tissues. Its presence in nonexcitable tissues suggests that it may also be sible exception of testis (Figure 7) . Smaller transcripts of approximately 1, 1.3, and 2.3 kb were also faintly involved in regulation of other proteins.
of these covalently attached lipids into the membrane bilayer. The N-terminal sequence of AKAP15 is similar to that of dually myristoylated and palmitoylated proteins including src-related nonreceptor tyrosine kinases, certain G␣ proteins, and eNOS (Resh, 1994; Mumby, 1997) .
To our knowledge, however, AKAP15 represents the first example of an AKAP to be dually acylated and the first example of an AKAP that is an intrinsic membrane protein. Interestingly, palmitoylation is a reversible process that is thought to allow palmitoylated proteins to cycle on and off the membrane (see Mumby, 1997) . Reversible membrane targeting of PKA by AKAP15 through this mechanism may therefore provide a novel mechanism for regulating PKA signaling.
AKAP15 Is Associated with Skeletal Muscle Calcium Channels
We previously showed that both PKA and AKAP15 copurify and coimmunoprecipitate with skeletal muscle L-type calcium channels extracted from skeletal muscle transverse tubule membranes (Gray et al., 1997). AKAP15 is also associated with skeletal muscle calcium channels when cotransfected in human embryonic kid- , 1997) , and we show here that AKAP15 and calcium channels are also colocalized PKA displays a broad substrate specificity in vitro and there ( Figure 5 ). Altogether, these data support the hyhas many potential protein targets within cells. It is pothesis that AKAP15 interacts directly with calcium therefore important to understand the basis for its subchannels at the triad junctions in intact skeletal muscle strate specificity in response to various hormones and fibers in order to localize PKA near the calcium channel neurotransmitters capable of triggering increases in infor rapid regulation of its functional activity. Other AKAPs tracellular cAMP. Spatial regulation of PKA activity is are targeted to the submembrane cytoskeleton but not thought to be maintained in part through subcellular to specific membrane protein substrates. Thus, AKAP15 targeting of PKA near restricted substrate pools by may define a new family of AKAPs whose function is AKAPs (Rubin, 1994; Dell'Acqua and Scott, 1997; Mur- to target PKA phosphorylation of specific membrane phy and Scott, 1998). While several AKAPs have been substrates. cloned and characterized, the functional importance of specific AKAPs in a cellular context remains largely unBlock of Interaction of PKA with AKAP15 Prevents characterized.
Voltage-Dependent Potentiation of Calcium Channel Function in Skeletal Muscle Cells AKAP15 Is Membrane Targeted by a Lipid Anchor
Voltage-dependent potentiation of calcium channels in We describe here the isolation, primary sequence deterskeletal muscle cells occurs on the millisecond time mination, and functional analysis of AKAP15, a novel scale and requires both PKA activity (Sculptoreanu et AKAP associated with skeletal muscle L-type calcium al., 1993a) and PKA anchoring near the channel by an channels. AKAPs are defined by their ability to bind RII AKAP (Johnson et al., 1994) . AKAP15 is the only AKAP with high affinity and by their proposed role in targeting detected in our skeletal muscle membrane fractions PKA to specific subcellular structures. Consistent with ( Figure 1A ), consistent with previous results indicating this, we have identified within AKAP15 both a predicted that AKAP79 is not expressed in muscle tissues (Carr amphipathic helix required for RII binding as well as an et al., 1991, 1992) . PKA, AKAP15, and calcium channels N-terminal domain, which mediates membrane targeting.
are colocalized in the triad junction in position to effect The amino acid sequences of these two domains are this rapid regulatory process (Burton et al., 1997; Figure completely conserved between rats and humans and 5). To assess the functional importance of colocalizalikely provide a general mechanism for AKAP15 to localtion of PKA, AKAP15, and calcium channels in voltageize PKA near membrane substrates. dependent potentiation, we have used AKAP15 peptides We demonstrate in this study that AKAP15 is dually containing the putative amphipathic helix implicated in myristoylated and palmitoylated when expressed in tsA-PKA binding. The AKAP15-derived RII-binding peptide 201 cells and that the consensus residues for myristoyla-AP2 binds RII in vitro while a proline-substituted peptide tion and palmitoylation in the N terminus are required (AP2-P) does not. Similarly, when introduced into culfor membrane targeting. It is likely, therefore, that memtured skeletal muscle cells, AP2 blocks voltage-dependent potentiation while AP2-P has no effect. This result brane association of AKAP15 occurs via direct insertion Kotsias et al., 1986; Dulhunty and Gage, 1988 We show here that AKAP15 is ubiquitously expressed in with 50 g of RII-biotin diluted to 10 ml in column buffer per 1 ml rat tissues. In addition to skeletal muscle, L-type calcium glutaraldehyde-cross-linked streptavidin agarose slurry for 1 hr at channels are expressed in the heart and nervous system, room temperature. Beads were then washed extensively with colwhere they serve as critical regulators of intracellular umn buffer at room temperature to remove unbound RII-biotin. calcium levels (Hess, 1990) . AKAP15 is expressed promPooled AKAP15-containing DEAE fractions were added to this RII affinity matrix and incubated at 4ЊC for 16 hr. Flow-through material inently in the heart and brain, suggesting that it may was collected, and the column was washed with a 50-fold excess mediate targeting of PKA to calcium channels in these volume of column buffer at 4ЊC. Bound AKAP15 was eluted by tissues. Like skeletal muscle calcium channels, voltageincubating in a 10-fold excess volume of 25 mM Tris (pH 7.4) and dependent potentiation of cardiac and brain L-type cal-0.1% SDS for 10 min at room temperature. Eluted AKAP15 was cium channels requires PKA (Sculptoreanu et al., 1993b;  concentrated using centriprep and centricon concentrators (Ami- Bourinet et al., 1994) . Furthermore, recent work has con, Inc).
demonstated that PKA modulation of L-type calcium channels following ␤-adrenergic stimulation of intact car- physiological role in regulation of skeletal muscle contracband was excised and subjected to in-gel trypsin digestion (Shevtion, AKAP15 is an excellent candidate for mediating the chenko et al., 1996) . Soluble tryptic fragments recovered from the digestion were resolved and characterized by microcolumn HPLC PKA targeting required for modulation of brain and cardiac and automated tandem mass spectrometry (Yates et al., 1995) . The L-type calcium channels. microcolumns were packed with PerSeptive Biosystems POROS 10 R2 (Boston, MA) to a length of 10-15 cm. The mobile phase used Experimental Procedures for gradient elution consisted of (solvent A) 0.5% acetic acid and (solvent B) acetonitrile/water 80:20 v/v containing 0.5% acetic acid.
Cell Lines
The gradient was linear from 0%-80% solvent B over 15 min. The tsA-201 cells are a subclone of the human embryonic kidney cell mass spectrometer used was a Finnigan MAT LCQ (San Jose, CA) line (HEK293) expressing SV40 T antigen and were a gift from Dr.
equipped with an electrospray ionization source. Tandem mass Robert Dubridge (Cell Genesis, Foster City, CA). The immortalized spectra were acquired automatically during the entire gradient run skeletal muscle 129CB3 cell line has been described elsewhere as previously described (Link et al., 1997) . Nucleic acid sequence (Pinç on- Raymond et al., 1991) .
databases were searched directly with the tandem mass spectra using the computer program SEQUEST (Eng et al., 1994) . The nuclePeptides, Antibodies, RII-Biotin, and GST-Fusion Proteins otide database was translated during the search to protein se-AP1 (AVQQYLEETQNKK), AP2 (AELVRLSKRLVENAVLKAVQQYLEE), quences in all six reading frames. The dbEST was obtained as an AP2-P (AELVRPSKRPVENAVLKAVQQYLEE), HT31, and HT31-P ASCII file in the FASTA format from the National Center for Biotechpeptides (Carr et al., 1991) were synthesized and purified in the nology Information by anonymous ftp. Each sequence returned by Protein Core of the University of Washington Molecular Pharmacol-SEQUEST was verified by manually inspecting the fit of the amino ogy Facility. Anti-AP1 antibodies were generated against the AP1 acid sequence to the corresponding tandem mass spectrum. peptide coupled to BSA and were purified on an AP1 affinity column.
Searching dbEST with mass spectra derived from AKAP15 samples For expression of GST-AKAP15 and GST-AKAP15 (L32P), the led to the identification of the AP1 sequence in a rat EST (GenBank AKAP15 coding sequence was PCR-amplified and subcloned into accession number AA072273). Searching dbEST with the entire rat the GST gene fusion vector pGEX-3X (Pharmacia). Anti-AKAP15
EST sequence led to the identification of a homologous human EST antibodies were generated against purified GST-AKAP15 and puri-(GenBank accession number AA223447). fied on protein-A Sepharose. Anti-GST antibodies were purchased and used according to the manufacturers instructions (Pharmacia Biotech, Inc.). RII␣ was expressed, purified, and biotinylated as Mammalian Expression and Membrane Targeting previously described (Gray et al., 1997) .
The rat AKAP15 open reading frame was PCR-amplified using primers specifying the wild-type protein or incorporating either the G2A, Immunoblotting, RII Overlay, and Peptide Competition Assays C5/6S, or G2A/C5/6S mutations. The resultant PCR products were Conditions for SDS-PAGE, electrotransfer, and protein detection via subcloned into the mammalian expression vector pcDNA3 (Inantibody or RII-biotin overlay were the same as used previously vitrogen, Inc.) for transfection into tsA-201 cells (Margolskee et al., (Gray et al., 1997) . Peptide competition assays involved a 30 min 1994). In experiments characterizing membrane association of wildpreincubation of peptide and RII-biotin prior to the overlay assay type and AKAP15 mutants, cells grown on a 150 mm culture dish as previously described (Gray et al., 1997) .
were transfected at 70% confluence, harvested 24 hr posttransfection, lysed, and dounce-homogenized in 6 ml 10 mM Tris (pH 7.4) Isolation of AKAP15 on ice. Following a low speed spin to remove nuclei and mitochonRabbit skeletal muscle microsomal membranes were prepared as dria, the lysed material was separated into membrane and soluble previously described (Fernandez et al., 1980) . Membranes were washed by stirring in a 20-fold excess volume of 10 mM CAPS fractions by centrifugation at 100,000 ϫ g for 30 min.
